GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » COGS-to-Revenue

MOVE (Movano) COGS-to-Revenue : 5.11 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Movano COGS-to-Revenue?

Movano's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.57 Mil. Its Revenue for the three months ended in Dec. 2024 was $0.11 Mil.

Movano's COGS to Revenue for the three months ended in Dec. 2024 was 5.11.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Movano's Gross Margin % for the three months ended in Dec. 2024 was -410.81%.

Movano COGS-to-Revenue Historical Data

The historical data trend for Movano's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Movano COGS-to-Revenue Chart

Movano Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial - - - - 2.97

Movano Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.43 - 16.90 5.11

Movano COGS-to-Revenue Calculation

Movano's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3.007 / 1.013
=2.97

Movano's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.567 / 0.111
=5.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Movano  (NAS:MOVE) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Movano's Gross Margin % for the three months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.567 / 0.111
=-410.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Movano COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Movano's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Movano Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » COGS-to-Revenue
Comparable Companies
WOK AEMD STME FOFA SINT AMIX IRME TNON ADMT TIVC ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
6800 Koll Center Parkway, Pleasanton, CA, USA, 94566
Website
https://www.movano.com
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
Executives
Jeremy Cogan officer: CFO 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Michael Aaron Leabman director, officer: CEO and President 207 VERITAS CT, SAN RAMON CA 94582
Emily Fairbairn director 10 ORINDA VIEW ROAD, ORINDA CA 94563
John Mastrototaro director 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Brian Cullinan officer: CFO 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Nan Kirsten Forte director 111 EIGHTH AVENUE, NEW YORK NY 10011
Ruben Caballero director C/O RESONANT INC. 10900 STONELAKE BLVD., SUITE 100, OFFICE 02-130, AUSTIN TX 78759
Dvine Irrevocable Trust 10 percent owner 6200 STONERIDGE MALL RD., SUITE 300, PLEASANTON CA 94588
Gregory S Tamkin 10 percent owner 303 RAY STREET, PLEASANTON CA 94566
Dorsey & Whitney Trust Co Llc 10 percent owner 401 EAST EIGHTH STREET, SUITE 319, SIOUX FALLS SD 57103
William Tai-wei Ho 10 percent owner C/O IN8BIO, INC., 79 MADISON AVENUE, NEW YORK NY 10016